Cargando…

Distinct interferon signatures stratify inflammatory and dysimmune myopathies

OBJECTIVE: The role of interferons (IFN) in the pathophysiology of primary inflammatory and dysimmune myopathies (IDM) is increasingly investigated, notably because specific neutralisation approaches may constitute promising therapeutic tracks. In present work we analysed the muscular expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rigolet, Muriel, Hou, Cyrielle, Baba Amer, Yasmine, Aouizerate, Jessie, Periou, Baptiste, Gherardi, Romain K, Lafuste, Peggy, Authier, François Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Connective Tissue Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397431/ https://www.ncbi.nlm.nih.gov/pubmed/30886734 http://dx.doi.org/10.1136/rmdopen-2018-000811

Ejemplares similares

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
por: Graf, Manuel, et al.
Publicado: (2022)

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
por: Meyer, Alain, et al.
Publicado: (2019)

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
por: Ide, Veerle, et al.
Publicado: (2018)

MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
por: Ukichi, Taro, et al.
Publicado: (2019)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
por: Bottai, Matteo, et al.
Publicado: (2017)

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Yeoh, Su-Ann, et al.
Publicado: (2022)

Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis
por: Rigolet, Muriel, et al.
Publicado: (2014)

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2016)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
por: Seror, Raphaèle, et al.
Publicado: (2015)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
por: van den Hoogen, Lucas L, et al.
Publicado: (2018)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
por: Chen, Bo, et al.
Publicado: (2019)

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines
por: Antunes, Margarida, et al.
Publicado: (2019)

IgG4-related diseases: state of the art on clinical practice guidelines
por: Iaccarino, Luca, et al.
Publicado: (2019)

Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
por: Cannizzo, Sara, et al.
Publicado: (2018)

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines
por: Sulli, Alberto, et al.
Publicado: (2018)

Mixed connective tissue disease: state of the art on clinical practice guidelines
por: Chaigne, Benjamin, et al.
Publicado: (2018)

Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET)
por: Mosca, Marta, et al.
Publicado: (2018)

Relapsing polychondritis: state of the art on clinical practice guidelines
por: Rednic, Simona, et al.
Publicado: (2018)

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
por: Howard Tripp, Nadia, et al.
Publicado: (2016)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey
por: Talarico, Rosaria, et al.
Publicado: (2020)

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study
por: Abisror, Noemie, et al.
Publicado: (2020)

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021)

Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
por: Ritschl, Valentin, et al.
Publicado: (2021)

Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud’s phenomenon: a detailed capillaroscopic analysis
por: Pacini, Greta, et al.
Publicado: (2022)

Pseudoacrocyanosis: a case for telemedicine in rheumatology
por: Manger, Bernhard, et al.
Publicado: (2022)

Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases
por: Zarbl, Joshua, et al.
Publicado: (2022)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023)

Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study
por: Abe, Kazuya, et al.
Publicado: (2023)

Exploring patient’s experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach
por: Marinello, Diana, et al.
Publicado: (2022)

Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort
por: Liem, Sophie I E, et al.
Publicado: (2023)

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?
por: Panagiotopoulos, Alexandros, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ekrm7gv94tjo320au434ioc0cp